Michelle Michels

Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial

Iacopo Olivotto, Artur Oręziak, Roberto Barriales‐Villa et al. · The Lancet · 2020 · 1.1K citations · Full text

Cardiomyopathy, Structural Heart Disease, Cardiovascular Disease +2

Cardiac Myosin-Binding Protein C Mutations and Hypertrophic Cardiomyopathy

Sabine J. van Dijk, Dennis Dooijes, Cristobal G. dos Remedios et al. · Circulation · 2009 · 324 citations · Full text

Myosin Sequestration Regulates Sarcomere Function, Cardiomyocyte Energetics, and Metabolism, Informing the Pathogenesis of Hypertrophic Cardiomyopathy

Christopher N. Toepfer, Amanda C. Garfinkel, Gabriela Venturini et al. · Circulation · 2020 · 308 citations · Full text

The Importance of Genetic Counseling, DNA Diagnostics, and Cardiologic Family Screening in Left Ventricular Noncompaction Cardiomyopathy

Yvonne M. Hoedemaekers, Kadir Çalişkan, Michelle Michels et al. · Circulation Cardiovascular Genetics · 2010 · 240 citations · Full text

Aficamten for Symptomatic Obstructive Hypertrophic Cardiomyopathy

Martin S. Maron, Ahmad Masri, Michael E. Nassif et al. · New England Journal of Medicine · 2024 · 230 citations · Full text